Clinical/Translational Research

The Division has a number of faculty members involved in various clinical and translational research activities. View a list of faculty and their research interests by category below.

Antibiotic stewardship

Bioinformatics, healthcare quality, patient safety and administrative data

  • Thomas C. Bailey, MD – Information technology to improve healthcare quality.
  • Victoria J. Fraser, MD – Use of large administrative data for risk prediction models, outcomes, costs and epidemiology of hospital acquired infections, antibiotic resistance, surgical site infections and adverse events.
  • William Claiborne Dunagan, MD, MS – Assessment and improvement of health care quality and patient safety.
  • Jennie H. Kwon, DO – Multidrug-resistant organism transmission dynamics, Clostridium difficile infections, healthcare epidemiology, patient safety and quality improvement.
  • Michael Lane, MD, MPHS, MSc – Improving clinical outcomes and the quality of care.
  • Margaret A. Olsen, PhD, MPH – Epidemiology of hospital acquired infections, particularly surgical site infections, and use of claims data for health outcomes research.
  • Mohammed (Rayan) J. Saeed, MBChB, MPH – Using large data to conduct observational research, to improve risk adjustment models for surgical site infections (SSI) to allow better comparison of infection risk between hospitals.
  • Keith F. Woeltje, MD, PhD – Improving the quality of healthcare delivery, especially in the area of preventing healthcare-associated infections (HAI).

C. difficile infection

  • Erik Dubberke, MD – Blood stream infection and Clostridium difficile associated disease in transplant and oncology patients.
  • Jennie H. Kwon, DO – Multidrug-resistant organism transmission dynamics, Clostridium difficile infections, healthcare epidemiology, patient safety and quality improvement.

Diagnostics and clinical microbiology

  • Neil W. Anderson, MD – Identifying microorganisms from blood cultures.
  • Carey-Ann Burnham, PhD – Antimicrobial resistance, with a focus on the transmission and epidemiology of multidrug resistant organisms (MDROs).
  •  Gregory Storch, MD – Virology and the molecular identification of new and emerging pathogens.

Global health

  • Philip Budge, MD, PhD – The global elimination and control of lymphatic fliariasis (LF) and other neglected tropical diseases.
  • Rupa Patel, MD, MPH, DTM&H – HIV prevention strategies among high-risk groups.
  • William G. Powderly, MD – HIV/AIDS, complications of antiretroviral therapy.
  • Andrej Spec, MD – Fungal infections, particularly in immunocompromised hosts, including Cryptococcus, Histoplasma, Candida and Aspergillus and other invasive molds.
  • Gary J. Weil, MD – Clinical parasitology, tropical medicine, travel medicine and international health.

Hospital epidemiology/infection prevention

  • Hilary M. Babcock, MD, MPH – Occupational exposures and nosocomial infections.
  • Courtney Chrisler, MD – Adverse events requiring hospital readmission.
  • Erik Dubberke, MD – Blood stream infection and Clostridium difficile associated disease in transplant and oncology patients.
  • Michael Durkin, MD – Improving patient care by reducing healthcare-associated infections.
  • Victoria J. Fraser, MD – Multicenter and single center studies of the epidemiology, risk factors, surveillance, outcomes and interventions to prevent hospital acquired infections and antimicrobial resistance.
  • Jennie H. Kwon, DO – Multidrug-resistant organism transmission dynamics, Clostridium difficile infections, healthcare epidemiology, patient safety and quality improvement.
  • Stephen Y. Liang, MD, MPHS – Trauma-related infections, orthopedic infections, skin and soft tissue infections, device infections, infection prevention.
  • Jay R. McDonald, MD – Infection control, antimicrobial resistance, surgical site infections.
  • Margaret A. Olsen, PhD, MPH – Epidemiology of hospital acquired infections, particularly surgical site infections, and use of claims data for health outcomes research.
  • Mohammed (Rayan) J. Saeed, MBChB, MPH – Using large data to conduct observational research, to improve risk adjustment models for surgical site infections (SSI) to allow better comparison of infection risk between hospitals.
  • David K. Warren, MD, MPH – Epidemiology and prevention of healthcare-associated infections.
  • Keith F. Woeltje, MD, PhD – Improving the quality of healthcare delivery, especially in the area of preventing healthcare-associated infections (HAI).

HIV

Immunocompromised/host transplant infectious diseases

  • Erik Dubberke, MD – Blood stream infection and Clostridium difficile associated disease in transplant and oncology patients.

Mycology

  • William G. Powderly, MD – HIV/AIDS, complications of antiretroviral therapy.
  • Andrej Spec, MD – Fungal infections, particularly in immunocompromised hosts, including Cryptococcus, Histoplasma, Candida and Aspergillus and other invasive molds.

Outpatient parenteral antimicrobial therapy

Sexually Transmitted Diseases (STDs)